Key facts
- Eli Health’s last known valuation is $25.6M (May 2025).
- It has raised $30.3M; the latest was Accelerator/Incubator in Jan 2026.
- Notable investors include Techstars, Flybridge (New York), BDC Capital, Garage Capital, 2048 Ventures — 31 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 31 names
- ·Watchlist + deal alerts for Eli Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Eli Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Eli Health
Developer of a hormone monitoring kit designed for real-time health insights. The company offers saliva-based testing technology to continuously track hormone levels, offering features such as cortisol and progesterone monitoring, personalized guidance, and daily data-driven insights, enabling women to proactively manage their hormonal health and improve overall well-being through accessible and innovative technology.
- Sector
- Healthcare
- HQ
- Montreal, Canada
- Founded
- 2019
- Employees
- 27
- Website
- eli.health/
- Ownership
- Privately Held (backing)
Eli Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Eli Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Eli Health in its N-PORT filings yet. We sweep new filings monthly.